TherapeuticsMD (TXMD) Raw Materials (2012 - 2022)

TherapeuticsMD's Raw Materials history runs 11 years deep, the most recent figure standing at $1.9 million for Q3 2022.

• Quarterly Raw Materials fell 44.19% year-over-year to $1.9 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $1.9 million (down 44.19% YoY) and the FY2021 annual result came in at $3.0 million, down 18.84% from the prior year.
• Raw Materials was $1.9 million for Q3 2022 at TherapeuticsMD, up from $434000.0 in the prior quarter.
• Across five years, Raw Materials topped out at $5.7 million in Q4 2019 and bottomed at $19400.0 in Q4 2018.
• A 5-year average of $3.0 million and a median of $3.6 million in 2020 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2019 — Raw Materials jumped 29290.45% — and 2022, when it tumbled 90.43%.
• TherapeuticsMD's Raw Materials stood at $19400.0 in 2018, then soared by 29290.45% to $5.7 million in 2019, then plunged by 34.27% to $3.7 million in 2020, then retreated by 18.84% to $3.0 million in 2021, then tumbled by 36.03% to $1.9 million in 2022.
• Business Quant data shows TXMD's Raw Materials at $1.9 million in Q3 2022, $434000.0 in Q2 2022, and $4.4 million in Q1 2022.